Targeting CD155 by rediocide-A overcomes tumour immuno-resistance to natural killer cells

CONTEXT: Therapeutic benefits of immunotherapy are restricted by cancer immune-resistance mechanisms. Rediocide-A (Red-A), a natural product extracted from Traditional Chinese Medicine, is a promising agent to battle against cancer which acts as an immune checkpoint inhibitor. OBJECTIVE: To investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Wanyi, Gong, Chenyuan, Yan, Xuewei, Si, Guifan, Fang, Chen, Wang, Lixin, Zhu, Xiaowen, Xu, Zihang, Yao, Chao, Zhu, Shiguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801066/
https://www.ncbi.nlm.nih.gov/pubmed/33399495
http://dx.doi.org/10.1080/13880209.2020.1865410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801066/
https://www.ncbi.nlm.nih.gov/pubmed/33399495
http://dx.doi.org/10.1080/13880209.2020.1865410

Ejemplares similares